Aurobindo Pharma Buyback 2026 vs Matrimony Buyback 2026 Details

Comparison between Aurobindo Pharma Buyback 2026 and Matrimony Buyback 2026 Details.

Buyback Details

Aurobindo Pharma Buyback 2026 is a Tender Offer buyback proposed to list at BSE, NSE while Matrimony Buyback 2026 Details is a Tender Offer proposed to list at BSE, NSE.

 Aurobindo Pharma LtdMatrimony.com Ltd.
LogoAurobindo Pharma Buyback 2026 LogoMatrimony Buyback 2026 Details Logo
Type of BuybackTender OfferTender Offer
Listing AtBSE, NSEBSE, NSE
Face Value₹10 per share₹5 per share
Buyback Price₹1475 per share₹655 per share
Issue Size54,23,728 shares8,93,129 shares
Issue Size (Amount)₹800.00 Crores₹58.50 Crores
Buyback Ratio
CategoryEntitlement RatioShares Offered
Small Shareholders7 : 618,13,560
General Category2 : 24946,10,168

Note:

  • Small Shareholders are retail shareholders under SEBI regulations.

  • General Category includes all other eligible shareholders.

  • Entitlement ratio is based on fully paid-up equity shares held on the record date.

CategoryEntitlement RatioShares Offered
Small Shareholders8 : 751,33,970
General Category4 : 457,59,159

Note:

  • Small Shareholders are retail shareholders under SEBI regulations.

  • General Category includes all other eligible shareholders.

  • Entitlement ratio is based on fully paid-up equity shares held on the record date.

RegistrarKfin Technologies Ltd.Kfin Technologies Ltd.
Lead ManagersAxis Capital Ltd.Saffron Capital Advisors Pvt.Ltd.
Necessity of the buyback

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

  • Return surplus funds to shareholders and enhance overall shareholder returns.
  • Optimise the Company’s capital structure.
  • Improve financial ratios such as earnings per share and return on equity.
  • Enhance long-term shareholder value.
  • Provide shareholders the flexibility to either participate in the Buyback for cash or retain their shareholding and benefit from an increased post-buyback ownership.

The Buyback is undertaken for the following reasons:

  1. The Buyback will help the Company to distribute surplus cash to its shareholders holding Equity Shares thereby enhancing the overall return for them.
  2. The Buyback, which is being implemented through the tender offer route as prescribed under the SEBI Buyback Regulations, would involve a reservation of up to 15% of the Equity Shares, which the Company proposes to buyback, for small shareholders or the actual number of Equity Shares entitled as per the shareholding of small shareholders on the Record Date, whichever is higher. The Company believes that this reservation for small shareholders would benefit a significant number of the Company’s public shareholders, who would be classified as “Small Shareholders”.
  3. The Buyback is generally expected to improve return on equity through distribution of cash and improve earnings per share by reduction in the equity base of the Company, thereby leading to a long-term increase in shareholders’ value; and
  4. The Buyback gives an option to the Eligible Shareholders to either (A) participate in the Buyback and receive cash in lieu of their Equity Shares which are accepted under the Buyback, or (B) not to participate in the Buyback and get a resultant increase in their percentage shareholding in the Company post the Buyback, without additional investment.

Buyback Timetable

Aurobindo Pharma Buyback 2026 and Matrimony Buyback 2026 Details buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Aurobindo Pharma Buyback 2026 Buyback record date is Apr 17, 2026. Matrimony Buyback 2026 Details Buyback record date is Jan 30, 2026.

 Aurobindo Pharma LtdMatrimony.com Ltd.
Record DateApr 17, 2026Jan 30, 2026
Offer Open DateApr 23, 2026Feb 05, 2026
Offer Closure DateApr 29, 2026Feb 11, 2026
Last date for receipt of tender formsApr 29, 2026Feb 12, 2026
Finalisation of buybackMay 07, 2026Feb 17, 2026
Last Date for settlment of bidsMay 07, 2026Feb 18, 2026
Last Date for extinguishment of sharesMay 18, 2026Feb 27, 2026

Financial Details and Other Relevent Information

Comparison of Aurobindo Pharma Buyback 2026 and Matrimony Buyback 2026 Details financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

 Aurobindo Pharma LtdMatrimony.com Ltd.
Financial

Company Financials (Restated Consolidated)

Period Ended31 Mar 202531 Mar 202431 Mar 2023
Assets49,784.9745,071.5139,889.99
Total Income32,345.5829,559.2525,145.97
Profit After Tax1,582.721,211.02684.85
EBITDA6,605.005,843.003,758.00
NET Worth32,647.0029,851.00
Reserves and Surplus20,476.0319,664.2317,975.44
Amount in ₹ Crore

Company Financials (Restated Consolidated)

Period Ended30 Sep 202531 Mar 202531 Mar 2024
Total Income112.41447.00472.79
Profit After Tax7.5544.9348.45
NET Worth247.09241.91292.08
Reserves and Surplus236.31231.13280.95
Amount in ₹ Crore
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Mar-2026 1330.90 1180.00 1272.16
Feb-2026 1250.85 1106.25 1179.45
Jan-2026 1270.40 1115.80 1176.03

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Dec-2025 561.10 475.55 517.55
Nov-2025 535.00 456.75 504.16
Oct-2025 544.85 502.45 512.20
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Mar-2026 1330.00 1179.80 1272.09
Feb-2026 1250.90 1106.00 1179.10
Jan-2026 1270.80 1116.20 1175.87

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Dec-2025 560.50 475.00 517.57
Nov-2025 545.00 475.25 504.22
Oct-2025 546.60 500.15 511.70

Compare with others

Compare:

Aurobindo Pharma Buyback 2026 and Matrimony Buyback 2026 Details